169262 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer; Specifically defined cancers of lung
THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER
#2MOLECULAR PROFILING OF TUMORS
#3SYNTHESIS AND COMPOSITION OF AMINO ACID LINKING GROUPS CONJUGATED TO COMPOUNDS USED FOR THE TARGETED IMAGING OF TUMORS
#4METHODS OF TREATING A NON-SMALL CELL LUNG CANCER USING AN ANTI-PD-1 ANTIBODY
#5METHODS OF TREATING AND DIAGNOSING LUNG CANCER
#6SPECIMEN ENRICHMENT FOR OPTICAL TOMOGRAPHY CELL ANALYSIS
#7METABOLITE PREDICTORS FOR LUNG CANCER
#8WORKFLOWS FOR DISCOVERY AND DEPLOYMENT OF DIAGNOSTIC ASSAYS COMBINING PROTEOMIC AND GENOMIC INFORMATION
#9METHOD OF DETECTING LUNG CANCER
#10PROGNOSTIC AND THERAPEUTIC METHODS FOR CANCER
#11METHODS FOR THE DETECTION AND TREATMENT OF LUNG CANCER
#12Combination Of Proteotypic Peptides For The Detection Of Proteins In The Pd-L1 Axis
#13GLYCOPROTEIN ASSESSMENT
#14BIOMARKER COMPOSITION FOR EARLY DETECTION AND PROGNOSIS PREDICTION OF LUNG ADENOCARCINOMA THROUGH AVEN GENE AND ITS ASSOCIATED GENES
#15MOLECULAR PROFILING OF TUMORS
#16METHODS OF DIAGNOSING AND TREATING LUNG CANCER
#17SELF-ADMINISTERED SYSTEM FOR BREAST CANCER SCREENING AND DIAGNOSIS USING BIOMARKER-SPECIFIC ANALYSIS
#18METHOD FOR THE SYNTHESIS OF EVOC PROBES
#19PLASMA AUTOANTIBODY BIOMARKERS FOR DIAGNOSIS OF LUNG CANCER
#20METHOD FOR PREDICTING PATIENT RESPONSE TO IMMUNOTHERAPY
#21METHOD OF ISOLATING AND ANALYZING CIRCULATING TUMOR CELLS
#22CYTOKINE PROFILING ANALYSIS
#23METHODS AND MICROFLUIDIC DEVICES FOR CHIROPTICAL DETECTION AND MUTATION ANALYSIS OF CANCER-ASSOCIATED EXTRACELLULAR VESICLES
#24BIOMARKER PANEL FOR DIAGNOSIS OR PREDICTION OF BRAIN METASTASIS OF LUNG CANCER, AND USE THEREOF
#25METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING TUMOR CELL MIMICS
#26METHODS OF TREATING CANCER USING ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1
#27Determining a Cancer Prognosis
#28BRAIN-METASTATIC LUNG CANCER CELL LINE AND USE OF NOGGIN AS MARKER FOR BRAIN METASTASIS OF LUNG CANCER
#29METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF LUNG CANCER TREATMENT AND METHOD FOR TREATING LUNG CANCER
#30BIOMARKERS FOR THE DETERMINATION OF SAMPLE ADEQUACY AND LUNG CANCER METASTASES
#31IMMUNOFLUORESCENCE AND FLUORESCENT-BASED NUCLEIC ACID ANALYSIS ON A SINGLE SAMPLE
#32SPECIMEN ENRICHMENT FOR OPTICAL TOMOGRAPHY ANALYSIS
#33NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST SMALL CELL LUNG CANCER AND OTHER CANCERS
#34USE OF BMMF1 REP PROTEIN AS DIAGNOSTIC MARKER FOR LUNG CANCER
#35RECEPTOR FOR VISTA
#36COMPOSITION AND METHOD OF TREATING A CANCER THROUGH AFFECTING MEMBRANE RECEPTORS OF CANCER CELLS AND THEIR DERIVED EXTRACELLULAR VESICLES
#37CEA ASSAY FOR PATIENT SELECTION IN CANCER THERAPY
#38PROTEIN CORONA BIOMARKER ANALYSIS
#39EVALUATING METHOD, EVALUATING APPARATUS, EVALUATING PROGRAM PRODUCT, EVALUATING SYSTEM, AND TERMINAL APPARATUS
#40METHOD OF PREDICTING A PATIENT'S BENEFIT FROM THERAPY WITH AN IMMUNE CHECKPOINT INHIBITOR
#41BIOMARKER SIGNATURES INDICATIVE OF EARLY STAGES OF CANCER
#42FRET ENZYMATIC SUBSTRATE AND USES THEREOF IN LUNG CANCER
#43METHOD FOR DETECTING AND ISOLATING CELL POPULATION CO-EXPRESSING CD45 AND EPCAM AND USE THEREOF
#44EXTRACELLULAR VESICLE DRUG ANALYSIS FOR REAL-TIME MONITORING OF TARGETED THERAPY
#45METHODS OF PROCESSING A BIOFLUID SAMPLE
#46Lung Cancer Prediction and Uses Thereof
#47METHOD FOR DIAGNOSING LUNG CANCER
#48GRP78-BINDING ANTIBODIES AND USE THEREOF IN DETECTING OR NEUTRALIZING GRP78
#49LUNG CANCER BIOMARKERS
#50Method for diagnosis of lung disease based on antibodies for microbial-derived vesicles
#51BIOLOGIC FOR THE TREATMENT OF CANCER
#52BIOMARKER FOR PREDICTING PROGNOSIS OF CANCER PATIENT, METHOD FOR PREDICTING PROGNOSIS OF CANCER PATIENT, METHOD FOR PREDICTING EFFECT OF CANCER THERAPEUTIC DRUG IN CANCER PATIENT, AND KIT FOR PREDICTING PROGNOSIS OF CANCER PATIENT
#53SELECTION OF PATIENTS FOR COMBINATION THERAPY
#54METHOD OF PREDICTING RESPONSE TO IMMUNOTHERAPY
#55HUMAN NSCLC CELL LINES AND USES THEREOF
#56BIOCHIP AND METHOD FOR TRACKING POSTOPERATIVE RECURRENCE STATUS OF PATIENT WITH LUNG ADENOCARCINOMA
#57FOCAL ADHESION KINASE SPLICING ISOMER AND APPLICATION THEREOF
#58Anti-GM2AP ANTIBODY AND APPLICATIONS THEREOF
#59METHODS FOR TREATING SMALL CELL LUNG CANCER AND OTHER NEUROENDOCRINE CANCERS
#60METHOD FOR TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
#61Non-Small Cell Lung Cancer Diagnosis and Treatment
#62METHOD AND SYSTEM FOR DIAGNOSING WHETHER AN INDIVIDUAL HAS LUNG CANCER
#63PROTEOGENOMIC ANALYSIS OF NON-SMALL CELL LUNG CANCER
#64DETECTION OF STAGE I LUNG CANCER BIOMARKERS
#65LUNG CANCER DIAGNOSIS USING BIOMARKERS FROM EXOSOMES
#66METHODS FOR THE DETECTION AND TREATMENT OF LUNG CANCER
#67LUNG-CANCER SPECIFIC T CELL DYSFUNCTION
#68METHOD OF DIAGNOSING EARLY-STAGE NON-SMALL CELL LUNG CANCER
#69STING LEVELS AS A BIOMARKER FOR CANCER IMMUNOTHERAPY
#70RECOMBINANT ANTIBODIES, KITS COMPRISING THE SAME, AND USES THEREOF
#71SEROLOGICAL BIOMARKERS FOR EARLY DIAGNOSIS OF LUNG CANCER
#72PROTEIN BIOMARKER AND USES THEREOF
#73Methods of assaying neoplastic and neoplasia-related cells and uses thereof
#74SPECIMEN ENRICHMENT FOR OPTICAL TOMOGRAPHY CELL ANALYSIS
#75METHODS FOR TREATING SMALL CELL LUNG CANCER AND OTHER NEUROENDOCRINE CANCERS
#76Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs
#77NEW METHOD TO PRONOSTIC LUNG CANCER
#78CANCER EXAMINATION METHOD AND CANCER TREATMENT AGENT
#79LUNG CANCER BIOMARKERS
#80COMPOSITIONS AND METHODS FOR DETECTION OF LUNG CANCER
#81Compositions and methods for assaying proteins and nucleic acids
#82METHODS AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY
#83PROGNOSTIC VALUE OF BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER HAVING STABLE DISEASE
#84COMPOSITIONS AND METHODS FOR PREDICTING RESPONSE TO NAPI2B-TARGETED THERAPY
#85METHODS AND KITS FOR THE DIAGNOSIS OF LUNG CANCER
#86ANTIBODIES FOR USE IN IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS TO DIAGNOSE CANCER
#87METHODS FOR THE DETECTION AND TREATMENT OF LUNG CANCER
#88USE OF ANTIGEN COMBINATION FOR DETECTING AUTOANTIBODIES IN LUNG CANCER
#89EXOSOMAL TUMOR BIOMARKERS AND COLLECTIONS THEREOF
#90USE OF A FIBRINOGEN CAPTURE AGENT TO DETECT A CIZ1 B-VARIANT
#91HOST SIGNATURES FOR PREDICTING IMMUNOTHERAPY RESPONSE
#92METHODS FOR DETECTING LUNG CANCER
#93METHODS RELATING TO LUNG CANCER
#94METHOD OF PERFORMING LUNG NODULE ASSESSMENT
#95METHOD OF DETECTING LUNG CANCER
#96RECEPTOR FOR VISTA
#97Anti-ROS1 antibody and use thereof
#98Methods of diagnosing and treating lung cancer
#99IL-1BETA BINDING ANTIBODIES FOR USE IN TREATING CANCER
#100BIOMARKERS FOR DETECTION OF LUNG CANCER
#101METHOD FOR PREDICTING EFFICACY OF TREATMENT OF LUNG CANCER PATIENT USING IMMUNE CHECKPOINT INHIBITOR
#102METHOD OF IDENTIFYING TREATMENT RESPONSIVE NON-SMALL CELL LUNG CANCER USING ANAPLASTIC LYMPHOMA KINASE (ALK) AS A MARKER
#103INTERTUMORAL HOMOGENEITY DETERMINED BY MiCK ASSAY
#104SPARC Assay
#105METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT
#106BIOMARKERS FOR PREDICTING THE RESPONSE TO CHECKPOINT INHIBITORS
#107Phage-displayed accessible recombinant targeted antibodies and methods of making same
#108Methods of treating gastrointestinal diseases characterized by inflammatory cells
#109Non-Invasive Gene Mutation Detection in Lung Cancer Patients
#110MOLECULAR PROFILING OF TUMORS
#1117-Gene Prognostic and Predictive Assay for Non-Small Cell Lung Cancer in Formalin Fixed and Paraffin Embedded Samples
#112Biomarker for Predicting Prognosis of Radiotherapy for Lung Cancer
#113METHODS FOR ANALYSIS OF TARGET MOLECULES IN BIOLOGICAL FLUIDS
#114MULTIPLE BIOMARKERS FOR DIAGNOSING LUNG CANCER AND USE THEREOF
#115Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs
#116Tumstatin Assay
#117GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78
#118USE OF CIRCULATING INTERLEUKIN-18 FOR PROGNOSTICATING AND TREATING RECURRENCE IN EARLY STAGE NON-SMALL CELL LUNG CANCER
#119METHODS FOR DETERMINING THE LIKELIHOOD OF LUNG CANCER
#120SYNTHESIS AND COMPOSITION OF AMINO ACID LINKING GROUPS CONJUGATED TO COMPOUNDS USED FOR THE TARGETED IMAGING OF TUMORS
#121DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS
#122USE OF IL-1BETA BINDING ANTIBODIES
#123METHOD FOR SEPARATING AND DETECTING EXOSOMES, AND KIT FOR SEPARATION AND DETECTION THEREOF
#124Methods for Identifying Cancer Patients for Combination Treatment
#125GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78
#126PREDICTIVE TEST FOR IDENTIFICATION OF EARLY STAGE NSCLC STAGE PATIENTS AT HIGH RISK OF RECURRENCE AFTER SURGERY
#127Methods of processing a biofluid sample
#128METHOD FOR PREDICTING IMMUNOTHERAPY RESPONSE WITH CORRECTED TMB
#129ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATING A TUMOR
#130METHODS FOR PREDICTING DRUG RESPONSIVENESS IN SAMPLES FROM CANCER SUBJECTS
#131GRP78-binding antibodies and uses thereof and selection of phage-displayed accessible recombinant targeted antibodies
#132METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF LUNG CANCER
#133Method for Predicting Therapeutic Response to Serine-Theronine Kinase Braf Inhibitor Drugs
#134EGFR AND ROS1 KINASE IN CANCER
#135METHOD OF DISCRIMINATING LUNG CANCER PATIENTS
#136HEXOKINASE 1 ISOFORM B FOR USE AS A PROGNOSIS MARKER AND SPECIFIC TARGET AGAINST CANCER
#137DETECTION OF BIOMARKERS FOR NON-SMALL CELL LUNG CANCER
#138METHODS FOR IDENTIFYING AND TREATING HIGH-PLASTICITY CELL STATE DRIVING TUMOR PROGRESSION IN LUNG CANCER
#139SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS
#140SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS
#141COMPOSITIONS AND METHODS FOR TREATING LUNG, COLORECTAL AND BREAST CANCER
#142PROVASOPRESSIN ANTAGONISTS AND USES THEREOF
#143Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#144MODULATION OF CANCER IMMUNITY WITH TYPE 2 INNATE LYMPHOID CELLS, INTERLEUKIN 33, AND/OR INTERFERON INDUCED PROTEIN 44
#145PRKC FUSIONS
#146COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#147Marker composition for diagnosing or predicting prognosis of lung cancer based on exosome overexpressing GCC2 gene or protein
#148USE OF KDM5A GENE AND ATRX GENE
#149ANTIBODIES AGAINST TRIM9 AND/OR TRIM67 IN PARANEOPLASTIC NEUROLOGICAL SYNDROMES
#150ANTI-GALECTIN-9 ANTIBODIES AND USES THEREOF
#151DNA REPAIR BLOOD TEST FOR PREDICTING RESPONSE OF LUNG CANCER PATIENTS TO IMMUNOTHERAPY
#152Compositions, methods and kits for diagnosis of lung cancer
#153Cytokine profiling analysis
#154Biomarkers of Breast and Lung Cancer
#155METHODS OF TREATING AND DIAGNOSING LUNG CANCER
#156Lung biomarkers and methods of use thereof
#157LIPID BIOMARKERS FOR CANCER SCREENING AND MONITORING
#158CHARACTERIZING METHYLATED DNA, RNA, AND PROTEINS IN THE DETECTION OF LUNG NEOPLASIA
#159CONSTRUCTS TARGETING LABYRINTHIN OR A PORTION THEREOF AND USES THEREOF
#160SYSTEMS AND METHODS FOR CHARACTERIZING AND TREATING DISEASE
#161THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER
#162Lung Cancer Biomarkers and Uses Thereof
#163METHOD OF DETECTING CANCER AND/OR TUBERCULOSIS
#164CAPTURE, IDENTIFICATION AND USE OF A NEW BIOMARKER OF SOLID TUMORS IN BODY FLUIDS
#165USE OF CIRCULATING TUMOR CELL MITOTIC INDEX IN CANCER STRATIFICATION AND DIAGNOSTICS
#166IGF2BP3 functional alterations and overexpression as a marker for cancer diagnosis and therapeutic response to IGF1R inhibitors
#167Antibody binding to carbonic anhydrase and use thereof
#168METHOD FOR IDENTIFICATION OF CANCER PATIENTS WITH DURABLE BENEFIT FROM IMMUNOTEHRAPY IN OVERALL POOR PROGNOSIS SUBGROUPS
#169Method Of Detecting Lung Cancer
#170SEROLOGICAL BIOMARKERS FOR EARLY DIAGNOSIS OF LUNG CANCER
#171METHODS FOR TREATING A SUBTYPE OF SMALL CELL LUNG CANCER
#172METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING TUMOR CELL MIMICS
#173Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#174ROS KINASE IN LUNG CANCER
#175METHODS AND COMPOSITIONS FOR AIDING IN THE DETECTION OF LUNG CANCER
#176IDENTIFICATION OF PROTEIN ASSOCIATED WITH HEPATOCELLULAR CARCINOMA, GLIOBLASTOMA AND LUNG CANCER
#177METHOD FOR PROVIDING INFORMATION ON THERAPEUTIC REACTION OF CANCER IMMUNOTHERAPY AND KIT USING SAME
#178LUNG CANCER PROTEIN EPITOMIC BIOMARKERS
#179INTERTUMORAL HOMOGENEITY DETERMINED BY MiCK ASSAY
#180COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER
#181Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#182System and method for isolating and analyzing cells
#183Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#184METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF
#185VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION
#186DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT
#187PREDICTIVE 7-GENE ASSAY AND PROGNOSTIC PROTEIN BIOMARKER FOR NON-SMALL CELL LUNG CANCER
#188NOVEL CANCER TREATMENT INVOLVING MODULATION OF IL-3 ACTIVITY
#189METHODS FOR PREDICTING RESPONSIVENESS OF LUNG CANCER PATIENTS TO HER2-TARGETING THERAPIES
#190Selection of patients for combination therapy
#191CD33 MONOCYTES AS A BIOMARKER
#192Early lung cancer detection by DNA methylation phenotyping of sputum-derived cells
#193Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
#194N-cadherin and FGFR1 and/or FGFR4 for use in predicting the response of patients to a lung cancer treatment and method and kit based on said use
#195SEROLOGICAL BIOMARKERS FOR EARLY DIAGNOSIS OF LUNG CANCER
#196Lung cancer biomarkers
#197Synthesis and composition of non-amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#198MPS PEPTIDES AND USE THEREOF
#199Compositions and methods for treating lung cancer
#200SPARC Assay
#201METHOD OF ISOLATING AND DETECTING CANCER STEM CELLS
#202THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS
#203CADM1 V9-recognizing antibody
#204Biologic for the treatment of cancer
#205BLOCKADE OF CCL18 SIGNALING VIA CCR6 AS A THERAPEUTIC OPTION IN FIBROTIC DISEASES AND CANCER
#206Methods of assaying neoplastic and neoplasia-related cells and uses thereof
#207Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#208Antitumor compounds and tumor diagnosis
#209Platform for assessment of the transcytosis of extracellular vesicles across endothelial barriers and uses thereof
#210SYSTEM AND METHOD FOR ISOLATING AND ANALYZING CELLS
#211METHODS FOR EVALUATING LUNG CANCER STATUS
#212Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs
#213STING levels as a biomarker for cancer immunotherapy
#214AUTOANTIBODIES AND AUTOANTIBODY-AUTOANTIGEN COMPLEXES AS BIOMARKERS OF SMALL CELL LUNG CANCER
#215MARKER COMPOSITION FOR DIAGNOSING OR PREDICTING PROGNOSIS OF LUNG CANCER BASED ON EXOSOME OVEREXPRESSING GCC2 GENE OR PROTEIN
#216IMMUNOLOGICAL COMPOSITION FOR DIAGNOSIS OF LUNG CANCER BY USING AUTOANTIBODY-ANTIGEN COMPLEX, DIAGNOSIS METHOD FOR LUNG CANCER BY USING SAME, AND LUNG CANCER DIAGNOSIS KIT COMPRISING SAME
#217Extracellular vesicles purified from dried blood cards
#218Prediction of response to immune-modulatory therapies
#219FGFR3 FUSION GENE AND PHARMACEUTICAL DRUG TARGETING SAME
#220Anti-CKAP4 monoclonal antibody
#221Biomarkers in Peripheral Blood Mononuclear Cells for Diagnosing or Detecting Lung Cancers
#222METHODS AND KITS FOR ANALYSIS OF HMGB1 ISOFORMS
#223Methods for analyzing rare circulating cells
#224Methods of diagnosing and treating lung cancer
#225Tumstatin Assay
#226Adenocarcinoma detection method
#227ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATING A TUMOR
#228METHODS AND MATERIALS FOR TREATING CANCER
#229MOLECULAR PROFILING FOR CANCER
#230METHODS OF PRODUCING CIRCULATING ANALYTE PROFILES AND DEVICES FOR PRACTICING SAME
#231ANTISULFATAED GLYCOSAMINOGLYCAN ANTIBODY
#232METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES
#233Extracellular vesicle proteins and their use for cancer diagnosis, predicting response to therapy, and treatment
#234Method for detecting and typing rare tumor cells in body fluid sample and kit therefor
#235Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#236Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#237RET inhibitor
#238COMPOSITIONS AND METHODS FOR DETECTING A NEOPLASIA
#239Saccharide-based biomarkers and therapeutics
#240METHODS OF IDENTIFYING INDIVIDUALS AT INCREASED RISK OF LUNG CANCER
#241Methods for diagnosis and treatment of patients having solid tumors
#242Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker
#243Methods relating to lung cancer
#244Method a System for a Biomarker Breath Test Using Mass Abnormalities in Gaseous Ions with Imaging Correlates
#245METHOD FOR DIAGNOSING LUNG CANCERS USING GENE EXPRESSION PROFILES IN PERIPHERAL BLOOD MONONUCLEAR CELLS
#246Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#247Classification and mutation prediction from histopathology images using deep learning
#248ISOFORMS OF GATA6 AND NKX2-1 AS MARKERS FOR DIAGNOSIS AND THERAPY OF CANCER AND AS TARGETS FOR ANTI-CANCER THERAPY
#249PRKC fusions
#250METHODS AND COMPOSITIONS FOR SINGLE CHAIN VARIABLE REGION ENOX2 ANTIBODIES FOR CANCER DETECTION AND DIAGNOSIS
#251Biomarkers for diagnosis of lung cancer
#252LUNG CANCER BIOMARKERS
#253Anti-ALK antibodies and methods for use thereof
#254IMMUNE MODULATORS IN COMBINATION WITH RADIATION TREATMENT
#255DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS
#256Light chain variable regions
#257DETECTION AND TARGETING OF TUMOR-PROMOTING NEUTROPHILS
#258Method, composition and kit for screening ALK or ROS-1 kinase inhibitor
#259Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1A1
#260METHOD FOR DETECTION OF LUNG CANCER
#261System and method for isolating and analyzing cells
#262Protein biomarker and uses thereof
#263Compositions and methods for detecting lung cancer
#264Lung protease nanosensors and uses thereof
#265Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
#266Dynamic BH3 profiling
#267Methods for identification, assessment, prevention, and treatment of cancer using PD-L1 isoforms
#268Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Lung Cancer in a HLA-A*0201-Positive Never-Smoker or Light-Former Smoker Patient
#269Lung cancer markers and uses thereof
#270System and method for isolating and analyzing cells
#271Determining a Cancer Prognosis
#272METHOD AND KITS FOR IDENTIFYING OF CDK9 INHIBITORS FOR THE TREATMENT OF CANCER
#273Anti-B7-H3 antibodies and diagnostic uses thereof
#274Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#275Materials and methods for evaluating and treating cancer
#276METHODS FOR THE DETECTION AND TREATMENT OF LUNG CANCER
#277IN VITRO METHOD FOR THE DIAGNOSIS OF LUNG CANCER
#278Specimen enrichment for optical tomography cell analysis
#279MOLECULAR PROFILING OF TUMORS
#280NEO-ANTIGEN SPECIFIC T CELLS
#281Method for Treating Cancer
#282Cancer detection using biopsy digital images
#283METHOD FOR TREATING EPSTEIN-BARR VIRUS - POSITIVE CANCER WITH IMMUNOTHERAPY
#284Method for the diagnosis and prognosis of cancer
#285High temperature selection of nucleotide-supported carbohydrate vaccines and resulting glycosylated oligonucleotides
#286Improved Methods Of Treating Lung Cancer Using Multiplex Proteomic Analysis
#287Method for identification of cancer patients with durable benefit from immunotherapy in overall poor prognosis subgroups
#288Methods for predicting responsiveness of a cancer to an immunotherapeutic agent and methods of treating cancer
#289Biomarkers for lung cancer stem cells
#290Biomarkers of Rapid Progression in Advanced Non-Small Cell Lung Cancer
#291Antibody or antibody fragment capable of binding to lung-specific X protein and use thereof
#292Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#293Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#294INTERTUMORAL HOMOGENEITY DETERMINED BY MiCK ASSAY
#295Nanoliposomal Targeting of Ephrin Receptor A2 (Epha2) and Related Diagnostics
#296Methods of diagnosing cancer using cancer testis antigens
#297METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON SMALL CELL LUNG CANCER (NSCLC) THAT COEXISTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
#298Use of c-Met Inhibitors to Treat Cancers Harbouring MET Mutations
#299SYSTEM AND METHOD FOR CANCER DETECTION
#300Oxidase activity of polymeric coated cerium oxide nano-particles